Florida Senate - 2017                                    SB 1472
       By Senator Galvano
       21-00525A-17                                          20171472__
    1                        A bill to be entitled                      
    2         An act relating to medicinal cannabis research and
    3         education; creating s. 1004.4351, F.S.; providing a
    4         short title; providing legislative intent; defining
    5         terms; establishing the Coalition for Medicinal
    6         Cannabis Research and Education within the H. Lee
    7         Moffitt Cancer Center and Research Institute, Inc.;
    8         providing a purpose for the coalition; establishing
    9         the Medicinal Cannabis Research and Education Board to
   10         direct the operations of the coalition; providing for
   11         the appointment of board members; providing for terms
   12         of office, reimbursement for certain expenses, and the
   13         conduct of meetings of the board; authorizing the
   14         board to appoint a coalition director; prescribing the
   15         duties of the coalition director; requiring the board
   16         to advise specified entities and officials regarding
   17         medicinal cannabis research and education in this
   18         state; requiring the board to annually adopt a
   19         Medicinal Cannabis Research and Education Plan;
   20         providing requirements for the plan; requiring the
   21         board to issue an annual report to the Governor and
   22         the Legislature by a specified date; specifying
   23         responsibilities of the H. Lee Moffitt Cancer Center
   24         and Research Institute, Inc.; providing an effective
   25         date.
   27         WHEREAS, cannabis, also known as marijuana, is produced
   28  from the cannabis plant, which produces a resin containing
   29  psychoactive compounds called cannabinoids, in addition to other
   30  compounds found in plants, such as terpenes and flavonoids, and
   31         WHEREAS, cannabis is a controlled substance and is
   32  classified as a Schedule I agent, a drug with a high potential
   33  for abuse, with no scientific evidence for medical use, and
   34         WHEREAS, the United States Food and Drug Administration has
   35  not approved the use of cannabis as a treatment for any medical
   36  condition, and
   37         WHEREAS, clinical trials conducted on medicinal cannabis
   38  are limited, and researchers must file an Investigational New
   39  Drug application with the United States Food and Drug
   40  Administration, obtain a Schedule I license from the United
   41  States Drug Enforcement Administration, and obtain approval from
   42  the National Institute on Drug Abuse to conduct clinical drug
   43  research with cannabis in the United States, and
   44         WHEREAS, due to the limited number of clinical studies on
   45  the medicinal use of marijuana, there is little or no unbiased
   46  data available to support the determination of safe and
   47  effective dosages of marijuana for specific illnesses, and
   48         WHEREAS, a significant number of Americans are seeking
   49  relief from pain and other medical symptoms through the use of
   50  cannabis, including cancer patients, patients suffering from
   51  refractory pain, and pediatric patients with refractory
   52  epilepsy, and
   53         WHEREAS, the electorate of Florida has enshrined in the
   54  State Constitution the right to obtain and use marijuana for
   55  medicinal purposes, NOW, THEREFORE,
   57  Be It Enacted by the Legislature of the State of Florida:
   59         Section 1. Section 1004.4351, Florida Statutes, is created
   60  to read:
   61         1004.4351Medicinal cannabis research and education.—
   62         (1) SHORT TITLE.—This section shall be known and may be
   63  cited as the “Medicinal Cannabis Research and Education Act.”
   64         (2) LEGISLATIVE INTENT.—The Legislature finds that:
   65         (a) The present state of knowledge concerning the use of
   66  cannabis to alleviate pain and treat illnesses is limited
   67  because permission to perform clinical studies on cannabis is
   68  difficult to obtain, with access to research-grade cannabis so
   69  restricted that little or no unbiased studies have been
   70  performed.
   71         (b) Under the State Constitution, cannabis is available for
   72  the treatment of certain debilitating medical conditions.
   73         (c) Additional clinical studies are needed to ensure that
   74  the residents of this state obtain the correct dosing,
   75  formulation, route, modality, frequency, quantity, and quality
   76  of cannabis for specific illnesses.
   77         (d) An effective medicinal cannabis research and education
   78  program would mobilize the scientific, educational, and medical
   79  resources that presently exist in this state to determine the
   80  appropriate and best use of cannabis to treat illness.
   81         (3) DEFINITIONS.—As used in this section, unless the
   82  context clearly indicates otherwise, the term:
   83         (a) “Board” means the Medicinal Cannabis Research and
   84  Education Board.
   85         (b) “Coalition” means the Coalition for Medicinal Cannabis
   86  Research and Education.
   87         (c) “Marijuana” or “medicinal cannabis” has the same
   88  meaning as provided in s. 29, Art. X of the State Constitution.
   90  EDUCATION.—
   91         (a) There is established within the H. Lee Moffitt Cancer
   92  Center and Research Institute, Inc., the Coalition for Medicinal
   93  Cannabis Research and Education. The purpose of the coalition is
   94  to conduct rigorous scientific research; provide education;
   95  disseminate research; and to guide policy for the adoption of a
   96  statewide policy on ordering and dosing practices for the
   97  medicinal use of cannabis. The coalition shall be physically
   98  located at the H. Lee Moffitt Cancer Center and Research
   99  Institute, Inc.
  100         (b) The Medicinal Cannabis Research and Education Board is
  101  established to direct the operations of the coalition. The board
  102  shall be composed of seven members appointed by the chief
  103  executive officer of the H. Lee Moffitt Cancer Center and
  104  Research Institute, Inc. Board members must have experience in a
  105  variety of scientific and medical fields, including, but not
  106  limited to, oncology, neurology, psychology, pediatrics,
  107  nutrition, and addiction. Members shall be appointed to 4-year
  108  terms and may be reappointed to serve additional terms. The
  109  chair shall be elected by the board from among its members to
  110  serve a 2-year term. The board shall meet no less than
  111  semiannually, at the call of the chair or, in his or her absence
  112  or incapacity, the vice chair. Four members constitute a quorum.
  113  A majority vote of the members present is required for all
  114  actions of the board. The board may prescribe, amend, and repeal
  115  a charter governing the manner in which it conducts its
  116  business. A board member shall serve without compensation but is
  117  entitled to be reimbursed for travel expenses by the coalition
  118  or the organization he or she represents in accordance with s.
  119  112.061.
  120         (c) The coalition shall be administered by a coalition
  121  director who shall be appointed by and serve at the pleasure of
  122  the board. The coalition director shall, subject to the approval
  123  of the board:
  124         1. Propose a budget for the coalition.
  125         2. Foster the collaboration of scientists, researchers, and
  126  other appropriate personnel in accordance with the coalition’s
  127  charter.
  128         3. Identify and prioritize the research to be conducted by
  129  the coalition.
  130         4. Prepare the Medicinal Cannabis Research and Education
  131  Plan for submission to the board.
  132         5. Apply for grants to obtain funding for research
  133  conducted by the coalition.
  134         6. Perform other duties as determined by the board.
  135         (d) The board shall advise the Board of Governors, the
  136  State Surgeon General, the Governor, and the Legislature with
  137  respect to medicinal cannabis research and education in this
  138  state. The board shall explore methods of implementing and
  139  enforcing medicinal cannabis laws in relation to cancer control,
  140  research, treatment, and education.
  141         (e) The board shall annually adopt a plan for medicinal
  142  cannabis research, known as the “Medicinal Cannabis Research and
  143  Education Plan,” which must be in accordance with state law and
  144  coordinate with existing programs in this state. The plan must
  145  include recommendations for the coordination and integration of
  146  medical, nursing, paramedical, community, and other resources
  147  connected with the treatment of debilitating medical conditions,
  148  research related to the treatment of such medical conditions,
  149  and education.
  150         (f) By February 15 of each year, the board shall issue a
  151  report to the Governor, the President of the Senate, and the
  152  Speaker of the House of Representatives on research projects,
  153  community outreach initiatives, and future plans for the
  154  coalition.
  156  AND RESEARCH INSTITUTE, INC.—The H. Lee Moffitt Cancer Center
  157  and Research Institute, Inc., shall allocate staff, information,
  158  and assistance, as the coalition’s budget permits, to assist the
  159  board in fulfilling its responsibilities.
  160         Section 2. This act shall take effect July 1, 2017.